Bitcoin 27.37
$13,551.55 0.202%
Ethereum -5.70
$382.59 -1.48894%
XRP -0.01
$0.24 -2.71991%
Zcash 2.26
$59.05 3.82786%
Monero -1.63
$122.80 -1.3271%
Tether 0.00
$1.00 -0.12242%
Elite 0.00
$0.00 11.45458%
Empowering Patients to Own Their Health Data
Token sale completed on 01 January
Goal: 2,000,000 USD

Embleema’s blockchain network offers a novel way to put patients at the center of clinical research by letting them own their health data, disrupting the slow, costly, manual and opaque process by which low quality health data is currently collected by pharmaceutical companies through Contrat Research Organisation, to monitor the efficacy of new investigational drugs. Connecting patients directly to medical research and incentivizing them to share their data with tokens, blockchain is the decentralized technology everyone was waiting for to move away from the current linear process of drug approvals, to a new iterative model where trustworthy digital health data is shared in real time between patients, life sciences and regulators. The 21st Century Cures Act (2016) gave the FDA a mandate to accelerate approvals if more patient real world data was shared proactively by pharma. Embleema’s blockchain speeds up this process with patient buy-in, accelerating time to market new drugs.

Token Sale: 10 October — 01 January
Token type
Min/Max Personal Cap
Market & Returns
Embleema (PreICO) token price
$348.5077536 1.0000000 ETH 348.5077536 BTC
Hype rate
Risk rate
ROI rate
Short review
Number of team Members
Team From

Add a comment

Member of The Internet Defense League